3M Tegaderm CHG apósito de fijación I.V. con clorexidina gluconata 1657R, 8,5 x 11,5 cm, 1 unidad/unidad/st.

An todo en uno antimicrobial y transparente CHG gel pad dressing allows continuous I.V. Sitio observación Indicated and clinically proven to reduce major catheter related infection by 67% in a randomised controlled trial in ICU patients with central venous and arterial catheters CHG gel pad provides antimicrobial activity suppressing skin flora regrowth for up to seven days and allows delivery of CHG under the catheter Indicated and clinically proven to reduce the risk of catheter colonisation in pacientes with central venous and arterial catheters Recommend use of waterproof cover over dressing and I.V. Sitio When Showering, sin látex, 1 unidad